Recent developments in immunological research are transforming our understanding of the body's protection. A key domain focuses on harnessing the power of engineered T cells, particularly CAR-T intervention, to target and eradicate cancer cells with unprecedented specificity. Simultaneously, investigations into the gut microbiome are revealing its